3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other
1
Gynecologic
1
Gastrointestinal
1
CNS
1
Breast
1
Conditions
Obesity
2
Overweight
1
Inflammation
1
Infertility
1
Endometrial Neoplasms
1
Breast Neoplasms
1
Interventions
semaglutide
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Topiramate
1
Tirzepatide
1
Tablets
1
Specimen Handling
1
Qsymia
1
Pregabalin
1
Phentermine
1
Omeprazole
1
Nutrition Assessment
1
Naltrexone
1
Methods
1
Liraglutide
1
Ketorolac
1
Glucagon-Like Peptide-1 Receptor
1
Exercise
1
Endurance Training
1
Diethylpropion
1
Diet
1
Bupropion
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Inflammation
×
Tablets
×
Other
×
Clear all
NCT06150898
2025-06-13
KePreSt
Jules Bordet Institute
Phase 2
Recruiting
112 enrolled